SCHEMBL6856353

SCHEMBL6856353

O=C([O-])c1cc(C(=O)[O-])cc(S(=O)(=O)[O-])c1.O=C([O-])c1cc(C(=O)[O-])cc(S(=O)(=O)[O-])c1.[Ba+2].[Ba+2].[Ba+2]

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 2/20 0.42
DUSP5 Q16690 3/20 0.41
DUSP6 Q16828 1/20 0.41
LCK P06239 1/20 0.40
FYN P06241 1/20 0.40
CA2 P00918 7/20 0.38
CA1 P00915 6/20 0.38
CYP1A2 P05177 3/20 0.35
LMNA P02545 3/20 0.35
TDP1 Q9NUW8 3/20 0.35
KDM4E B2RXH2 2/20 0.35
MEN1 O00255 2/20 0.35
POLB P06746 2/20 0.35
CYP3A4 P08684 2/20 0.35
MAPT P10636 2/20 0.35
CYP2C9 P11712 2/20 0.35
PKM P14618 2/20 0.35
NFKB1 P19838 2/20 0.35
APEX1 P27695 2/20 0.35
CYP2C19 P33261 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Potassium Ion SCHEMBL2965238 0.95 PTPN1 (0.42) PTPN1DUSP5DUSP6LCKFYN
Zinc Ion SCHEMBL2469908 0.95 PTPN1 (0.42) PTPN1DUSP5DUSP6LCKFYN
Lithium Ion SCHEMBL1645513 0.95 PTPN1 (0.42) PTPN1DUSP5DUSP6LCKFYN
SCHEMBL6292110 0.95 PTPN1 (0.42) PTPN1DUSP5DUSP6LCKFYN
SCHEMBL6906244 0.95 PTPN1 (0.42) PTPN1DUSP5DUSP6LCKFYN
SCHEMBL260682 0.95 DUSP5 (0.45) PTPN1DUSP5DUSP6LCKFYN
SCHEMBL5009688 0.90 PTPN1 (0.38) PTPN1DUSP5DUSP6LCKFYN
SCHEMBL9574902 0.88 LCK (0.53) PTPN1DUSP5DUSP6LCKFYN
SCHEMBL7714612 0.84 LCK (0.48) PTPN1DUSP5DUSP6LCKFYN
Terephthalic Acid SCHEMBL8053920 0.83 CA2 (0.48) PTPN1DUSP5DUSP6CA2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117500967-A Spunbond nonwoven fabric and separation membrane comprising same 东丽株式会社 2024-02-02 CN disclosed
WO-2023026973-A1 SPUNBONDED NONWOVEN FABRIC AND SEPARATION MEMBRANE CONTAINING SAME 東レ株式会社 2023-03-02 WO disclosed
WO-2020213519-A1 POLYESTER COMPOSITION 東レ株式会社 2020-10-22 WO disclosed
CN-109476832-A Copolyester and composite fibre comprising the copolyester 东丽株式会社 2019-03-15 CN disclosed
US-6830859-B2 Electrostatic latent images; containing barium salt of sulfoisophthalic acid RICOH COMPANY, LTD. (JP) 2004-12-14 US disclosed
US-20030077534-A1 Charge control agent and toner using same RICOH COMPANY, LTD. (JP) 2003-04-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030077534-A1 Charge control agent and toner using same BET1, SMARCA5, SMARCA1 PTPN1 1121/4885DUSP5 2582/4885DUSP6 2900/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.